Shoucheng Invests in Pellucid Optics to Accelerate High-End Optical Imaging Breakthroughs

Bulletin Express04-20

Shoucheng Holdings Limited (Shoucheng) has disclosed a strategic investment in Pellucid Optics Technology (Nantong) Co., Ltd. through a fund managed by a wholly owned subsidiary under Shoucheng Capital.

The capital injection is intended to strengthen Pellucid Optics’ talent recruitment, research and development, and product-iteration capabilities, thereby deepening the company’s technological moat in live-cell, label-free super-resolution imaging based on Optical Diffraction Tomography (ODT).

Pellucid Optics positions itself as a domestic innovator in high-end optical instruments, collaborating with leading global manufacturers to challenge the sector’s existing international dominance. Shoucheng expects the investment to expedite Pellucid Optics’ technology industrialisation and broaden its competitive advantages in life-science research and high-end medical equipment.

Consistent with its strategic focus on cutting-edge technologies, Shoucheng plans to continue leveraging capital resources and industrial synergy to support portfolio companies in commercialising scientific breakthroughs and advancing China’s high-end medical device and life-science instrument industries.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1126245237?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-20 16:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1126245237","market":"hk","top_or_hot":-1,"title":"Shoucheng Invests in Pellucid Optics to Accelerate High-End Optical Imaging Breakthroughs","media":"Bulletin Express","content":"<p>Shoucheng Holdings Limited (Shoucheng) has disclosed a strategic investment in Pellucid Optics Technology (Nantong) Co., Ltd. through a fund managed by a wholly owned subsidiary under Shoucheng Capital.</p>\n<p>The capital injection is intended to strengthen Pellucid Optics’ talent recruitment, research and development, and product-iteration capabilities, thereby deepening the company’s technological moat in live-cell, label-free super-resolution imaging based on Optical Diffraction Tomography (ODT).</p>\n<p>Pellucid Optics positions itself as a domestic innovator in high-end optical instruments, collaborating with leading global manufacturers to challenge the sector’s existing international dominance. Shoucheng expects the investment to expedite Pellucid Optics’ technology industrialisation and broaden its competitive advantages in life-science research and high-end medical equipment.</p>\n<p>Consistent with its strategic focus on cutting-edge technologies, Shoucheng plans to continue leveraging capital resources and industrial synergy to support portfolio companies in commercialising scientific breakthroughs and advancing China’s high-end medical device and life-science instrument industries.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Shoucheng Invests in Pellucid Optics to Accelerate High-End Optical Imaging Breakthroughs</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nShoucheng Invests in Pellucid Optics to Accelerate High-End Optical Imaging Breakthroughs\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-04-20 16:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shoucheng Holdings Limited (Shoucheng) has disclosed a strategic investment in Pellucid Optics Technology (Nantong) Co., Ltd. through a fund managed by a wholly owned subsidiary under Shoucheng Capital.</p>\n<p>The capital injection is intended to strengthen Pellucid Optics’ talent recruitment, research and development, and product-iteration capabilities, thereby deepening the company’s technological moat in live-cell, label-free super-resolution imaging based on Optical Diffraction Tomography (ODT).</p>\n<p>Pellucid Optics positions itself as a domestic innovator in high-end optical instruments, collaborating with leading global manufacturers to challenge the sector’s existing international dominance. Shoucheng expects the investment to expedite Pellucid Optics’ technology industrialisation and broaden its competitive advantages in life-science research and high-end medical equipment.</p>\n<p>Consistent with its strategic focus on cutting-edge technologies, Shoucheng plans to continue leveraging capital resources and industrial synergy to support portfolio companies in commercialising scientific breakthroughs and advancing China’s high-end medical device and life-science instrument industries.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"00697","symbol_name":"首程控股","start_time":0,"source_url":"","article_id":"1126245237","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1126245237","pubTimestamp":1776674608,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Shoucheng Holdings Limited (Shoucheng) has disclosed a strategic investment in Pellucid Optics Technology (Nantong) Co., Ltd. through a fund managed by a wholly owned subsidiary under Shoucheng...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"00697":"首程控股"},"translate_title":"首程入股Pellucid Optics加速高端光学成像突破","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00697":1},"content_text":"Shoucheng Holdings Limited (Shoucheng) has disclosed a strategic investment in Pellucid Optics Technology (Nantong) Co., Ltd. through a fund managed by a wholly owned subsidiary under Shoucheng Capital.\nThe capital injection is intended to strengthen Pellucid Optics’ talent recruitment, research and development, and product-iteration capabilities, thereby deepening the company’s technological moat in live-cell, label-free super-resolution imaging based on Optical Diffraction Tomography (ODT).\nPellucid Optics positions itself as a domestic innovator in high-end optical instruments, collaborating with leading global manufacturers to challenge the sector’s existing international dominance. Shoucheng expects the investment to expedite Pellucid Optics’ technology industrialisation and broaden its competitive advantages in life-science research and high-end medical equipment.\nConsistent with its strategic focus on cutting-edge technologies, Shoucheng plans to continue leveraging capital resources and industrial synergy to support portfolio companies in commercialising scientific breakthroughs and advancing China’s high-end medical device and life-science instrument industries.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1126245237","isCrawlerRequest":true}